Granules India Limited has officially communicated the record date for its final dividend distribution for the financial year ended March 31, 2026. The pharmaceutical company sent formal intimation to stock exchanges on April 29, 2026, setting July 30, 2026 as the crucial date for dividend eligibility.

Official Record Date Communication

The company has established the following parameters for its dividend distribution through official regulatory communication:

Regulatory Compliance Framework

The announcement was made in strict compliance with Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to inform stock exchanges about record dates for corporate actions, including dividend distributions.

The formal communication was addressed to both National Stock Exchange India Limited and BSE Limited, where Granules India shares are traded under scrip codes NSE-GRANULES and BSE-532482 respectively.

Digital Authentication and Authorization

Chaitanya Tummala, Company Secretary & Compliance Officer, digitally signed the official communication on April 29, 2026 at 14:11:19 +05'30'. The document carries the official blue circular stamp of Granules India Limited, Hyderabad, ensuring authenticity and regulatory compliance.

Shareholder Eligibility Criteria

Shareholders holding Granules India Limited shares on the record date of July 30, 2026 will be eligible to receive the final dividend for FY26. This cut-off date determines dividend entitlement based on registered shareholding as per company records on the specified date.

Corporate Information

Granules India Limited operates under CIN: L24110TG1991PLC012471 with its registered office located at 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad – 500084, Telangana. The company maintains corporate communication through official channels including Tel: +91 40 69043500 and email: mail@granulesindia.com .

Granules India Limited has made the audio recording of its Q4 FY26 earnings conference call available online following the successful completion of the scheduled session on April 29, 2026. The pharmaceutical company filed the update on April 29, 2026, under Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conference Call Completion and Recording Availability

The earnings conference call was conducted as scheduled on Wednesday, April 29, 2026, at 5:00 PM IST, where the company discussed its Q4 FY26 performance and overall business developments for the financial year ended March 31, 2026. The audio recording has been uploaded to the company's official website for stakeholder access.

Management Participation

The conference call featured senior management personnel who addressed queries and provided detailed insights into the company's performance. The participating executives represented key functional areas of the organization.

Regulatory Compliance and Documentation

The notification was filed pursuant to Regulation 46 of SEBI regulations, which mandates companies to maintain and update their websites with relevant information for stakeholders. The intimation was signed by Chaitanya Tummala, Company Secretary & Compliance Officer, and digitally authenticated on April 29, 2026, at 20:03:37 +05'00'.

Granules India Limited is headquartered at 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad – 500084, Telangana, India. The company maintains its investor relations through dedicated resources and provides regular updates to stakeholders through multiple communication channels.